Bringing a wealth of experience in the technology and healthcare sectors, the fund manager has successfully executed over 50 deals across Asia and North America. Their operator-first approach emphasizes collaboration with portfolio companies, driving value creation from initial investment through to exit. Noteworthy exits include leading firms in the biotechnology space, showcasing a strong ability to identify and capitalize on emerging trends. This strategic style is complemented by a data-driven investment strategy, ensuring informed decision-making at every stage of the investment cycle.